AGEN
Price
$4.27
Change
+$0.11 (+2.64%)
Updated
Sep 3, 04:59 PM (EDT)
Capitalization
135.74M
JAGX
Price
$1.68
Change
+$0.01 (+0.60%)
Updated
Sep 3 closing price
Capitalization
3.65M
Interact to see
Advertisement

AGEN vs JAGX

Header iconAGEN vs JAGX Comparison
Open Charts AGEN vs JAGXBanner chart's image
Agenus
Price$4.27
Change+$0.11 (+2.64%)
Volume$6.25K
Capitalization135.74M
Jaguar Health
Price$1.68
Change+$0.01 (+0.60%)
Volume$45.24K
Capitalization3.65M
AGEN vs JAGX Comparison Chart in %
Loading...
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AGEN vs. JAGX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGEN is a Buy and JAGX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (AGEN: $4.16 vs. JAGX: $1.67)
Brand notoriety: AGEN and JAGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AGEN: 45% vs. JAGX: 105%
Market capitalization -- AGEN: $135.74M vs. JAGX: $3.65M
AGEN [@Biotechnology] is valued at $135.74M. JAGX’s [@Biotechnology] market capitalization is $3.65M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AGEN’s FA Score shows that 1 FA rating(s) are green whileJAGX’s FA Score has 1 green FA rating(s).

  • AGEN’s FA Score: 1 green, 4 red.
  • JAGX’s FA Score: 1 green, 4 red.
According to our system of comparison, AGEN is a better buy in the long-term than JAGX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AGEN’s TA Score shows that 4 TA indicator(s) are bullish while JAGX’s TA Score has 3 bullish TA indicator(s).

  • AGEN’s TA Score: 4 bullish, 5 bearish.
  • JAGX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, AGEN is a better buy in the short-term than JAGX.

Price Growth

AGEN (@Biotechnology) experienced а -10.15% price change this week, while JAGX (@Biotechnology) price change was -5.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +16.10%, and the average quarterly price growth was +32.67%.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AGEN($136M) has a higher market cap than JAGX($3.65M). AGEN has higher P/E ratio than JAGX: AGEN (0.14) vs JAGX (0.04). AGEN YTD gains are higher at: 51.825 vs. JAGX (-93.386). JAGX has higher annual earnings (EBITDA): -38.75M vs. AGEN (-74.93M). AGEN has more cash in the bank: 9.53M vs. JAGX (2.21M). JAGX has less debt than AGEN: JAGX (30.5M) vs AGEN (90.5M). AGEN has higher revenues than JAGX: AGEN (102M) vs JAGX (11.8M).
AGENJAGXAGEN / JAGX
Capitalization136M3.65M3,722%
EBITDA-74.93M-38.75M193%
Gain YTD51.825-93.386-55%
P/E Ratio0.140.04322%
Revenue102M11.8M864%
Total Cash9.53M2.21M432%
Total Debt90.5M30.5M297%
FUNDAMENTALS RATINGS
AGEN vs JAGX: Fundamental Ratings
AGEN
JAGX
OUTLOOK RATING
1..100
6054
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
12
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
5997
P/E GROWTH RATING
1..100
25100
SEASONALITY SCORE
1..100
5047

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JAGX's Valuation (12) in the Pharmaceuticals Generic industry is significantly better than the same rating for AGEN (96) in the Biotechnology industry. This means that JAGX’s stock grew significantly faster than AGEN’s over the last 12 months.

JAGX's Profit vs Risk Rating (100) in the Pharmaceuticals Generic industry is in the same range as AGEN (100) in the Biotechnology industry. This means that JAGX’s stock grew similarly to AGEN’s over the last 12 months.

JAGX's SMR Rating (100) in the Pharmaceuticals Generic industry is in the same range as AGEN (100) in the Biotechnology industry. This means that JAGX’s stock grew similarly to AGEN’s over the last 12 months.

AGEN's Price Growth Rating (59) in the Biotechnology industry is somewhat better than the same rating for JAGX (97) in the Pharmaceuticals Generic industry. This means that AGEN’s stock grew somewhat faster than JAGX’s over the last 12 months.

AGEN's P/E Growth Rating (25) in the Biotechnology industry is significantly better than the same rating for JAGX (100) in the Pharmaceuticals Generic industry. This means that AGEN’s stock grew significantly faster than JAGX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AGENJAGX
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 20 days ago
84%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
AGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JAGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REPYF16.380.33
+2.05%
Repsol S.A.
EBYH0.16N/A
N/A
E-Buy Home Inc.
JCDXF17.25N/A
N/A
JC Decaux SA
ORENF4.41-0.11
-2.43%
Origin Enterprises PLC
MGMLF0.09N/A
-3.83%
Maple Gold Mines Ltd.

AGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, AGEN has been closely correlated with NCNA. These tickers have moved in lockstep 92% of the time. This A.I.-generated data suggests there is a high statistical probability that if AGEN jumps, then NCNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AGEN
1D Price
Change %
AGEN100%
-0.48%
NCNA - AGEN
92%
Closely correlated
-6.58%
NBY - AGEN
90%
Closely correlated
+28.09%
TAOX - AGEN
90%
Closely correlated
+6.70%
ALLR - AGEN
88%
Closely correlated
+3.90%
JAGX - AGEN
87%
Closely correlated
+2.45%
More

JAGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, JAGX has been closely correlated with CDTX. These tickers have moved in lockstep 90% of the time. This A.I.-generated data suggests there is a high statistical probability that if JAGX jumps, then CDTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JAGX
1D Price
Change %
JAGX100%
+2.45%
CDTX - JAGX
90%
Closely correlated
-2.45%
NCNA - JAGX
89%
Closely correlated
-6.58%
TAOX - JAGX
89%
Closely correlated
+6.70%
RNAC - JAGX
89%
Closely correlated
-2.09%
NBY - JAGX
88%
Closely correlated
+28.09%
More